Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
FPHAX vs GDOC
Shared holdings
7
FPHAX covered by GDOC
30.29%
GDOC covered by FPHAX
30.29%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
FPHAX (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 24.13% | |
| GSK plc SPONSORED ADR | 9.65% | |
| JOHNSON&JOHNSON | 7.22% | |
| UCB SA | 4.80% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 4.73% | |
| ASTRAZENECA PLC | 4.72% | |
| GILEAD SCIENCES INC | 4.45% | |
| MERCK & CO | 4.40% | |
| ELANCO ANIMAL HEALTH INC | 4.23% | |
| Fidelity Securities Lending Cash Central Fund | 4.08% | |
| LEGEND BIOTECH CORP SPON ADR | 3.12% | |
| JAZZ PHARMA PLC | 2.74% | |
| MODERNA INC | 2.33% | |
| ROYALTY PHARMA PLC | 2.19% | |
| VIATRIS INC | 1.63% | |
| FINANCIERE DE TU | 1.55% | |
| BIONTECH SE ADR | 0.92% | |
| MERCK Kommanditgesellschaft auf Aktien | 0.91% | |
| BIOGEN INC | 0.89% | |
| OCULAR THERAPEUTIX INC | 0.75% | |
| BEAM THERAPEUTICS INC | 0.75% | |
| XENON PHARMACEUTICALS INC | 0.73% | |
| UNIQURE N.V. | 0.70% | |
| CAPRICOR THERAPEUTICS INC | 0.69% | |
| PTC THERAPEUTICS INC | 0.67% | |
| KYMERA THERAPEUTICS INC | 0.59% | |
| PHIBRO ANIMAL HEALTH CORP CL A | 0.52% | |
| AXSOME THERAPEUTICS INC | 0.51% | |
| ANNEXON INC | 0.45% | |
| Ascendis Pharma A/S | 0.36% | |
| CORCEPT THERAPEUTICS INC | 0.36% | |
| AGOMAB THERAPEUTICS SA SER D PC PP | 0.34% | |
| INTELLIA THERAPEUTICS INC | 0.33% | |
| CRINETICS PHARMACEUTICALS INC | 0.32% | |
| Fidelity Cash Central Fund | 0.30% | |
| HARMONY BIOSCIENCES HOLDINGS INC | 0.29% | |
| ARROWHEAD PHARMACEUTICALS INC | 0.26% | |
| WAVE LIFE SCIENCES LTD | 0.26% | |
| VERA THERAPEUTICS INC | 0.26% | |
| AMYLYX PHARMACEUTICALS INC | 0.25% | |
| DISC MEDICINE INC | 0.23% | |
| DEFINIUM THERAPEUTICS INC | 0.21% | |
| IDORSIA LTD | 0.21% | |
| SUMMIT THERAPEUTICS INC | 0.18% | |
| EDGEWISE THERAPEUTICS INC | 0.16% | |
| ARRIVENT BIOPHARMA INC | 0.16% | |
| EVOZYNE INC SER B PC PP | 0.14% | |
| VIKING THERAPEUTICS INC | 0.14% | |
| PARAGON BIOSCIENCES EMALEX CAPITAL INC SER D-3 PC PP | 0.12% | |
| CASTLE CREEK BIOSCIENCES INC SER D-2 PC PP | 0.09% |
GDOC (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 12.20% | |
| JOHNSON&JOHNSON | 8.10% | |
| ASTRAZENECA PLC | 6.41% | |
| MERCK & CO | 5.99% | |
| BOSTON SCIENTIFIC CORP | 5.81% | |
| THERMO FISHER SCIENTIFIC INC | 4.62% | |
| INTUITIVE SURGICAL INC | 4.47% | |
| GUARDANT HEALTH INC | 3.73% | |
| HOYA CORP | 3.63% | |
| ARGENX SE SPONSORED ADR | 3.60% | |
| CENCORA INC | 3.39% | |
| ABBOTT LABS | 3.13% | |
| LONZA GROUP -REG | 2.94% | |
| AGILENT TECHNOLOGIES INC | 2.91% | |
| DEXCOM INC | 2.68% | |
| ROIVANT SCIENCES LTD | 2.23% | |
| METTLER-TOLEDO INTL INC | 1.77% | |
| APOGEE THERAPEUTICS INC | 1.62% | |
| Sartorius Stedim Biotech S.A. | 1.59% | |
| IONIS PHARMACEUTICALS INC | 1.41% | |
| QIAGEN NV | 1.39% | |
| REPLIGEN CORP | 1.26% | |
| INSMED INC | 1.22% | |
| PENUMBRA INC | 1.14% | |
| Goldman Sachs Treasury Obligations Fund Institutional Class | 1.09% | |
| NATERA INC | 1.05% | |
| XENON PHARMACEUTICALS INC | 1.03% | |
| ROYALTY PHARMA PLC | 1.01% | |
| UNITEDHEALTH GRP | 1.01% | |
| CYTOKINETICS INC | 0.98% | |
| BRIDGEBIO PHARMA INC | 0.92% | |
| MADRIGAL PHARMACEUTICALS INC | 0.89% | |
| RHYTHM PHARMACEUTICALS INC | 0.88% | |
| CG ONCOLOGY INC | 0.83% | |
| ARCELLX INC | 0.82% | |
| GENEDX HOLDINGS CORP-A | 0.59% | |
| REVOLUTION MEDICINES INC | 0.52% | |
| INSULET CORP | 0.47% | |
| ULTRAGENYX PHARMA INC | 0.37% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.30% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.